Page last updated: 2024-10-25

deferoxamine and Gasser Syndrome

deferoxamine has been researched along with Gasser Syndrome in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
"In 10 children with chronic renal failure, there was a linear correlation (r = 0."1.28Intraperitoneal deferoxamine therapy for iron overload in children undergoing CAPD. ( Andreoli, SP; Cohen, M, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreoli, SP1
Cohen, M1

Other Studies

1 other study available for deferoxamine and Gasser Syndrome

ArticleYear
Intraperitoneal deferoxamine therapy for iron overload in children undergoing CAPD.
    Kidney international, 1989, Volume: 35, Issue:6

    Topics: Adolescent; Biomarkers; Deferoxamine; Female; Ferritins; Hemolytic-Uremic Syndrome; Humans; Infusion

1989